SCHEME 1. Asymmetric Reductive Acylation of Ketoximes
to Amides
Asymmetric Reductive Acylation of Aromatic
Ketoximes by Enzyme-Metal Cocatalysis
Kiwon Han, Jaiwook Park,* and Mahn-Joo Kim*
Department of Chemistry, Pohang UniVersity of Science and
Technology, San-31 Hyojadong, Pohang 790-784, Korea
ReceiVed February 2, 2008
oxidation of alcohols,7 the hydrogenolysis of epoxides,8 and the
dynamic kinetic resolution (DKR) of primary amines.9 The Pd
nanocatalyst, readily prepared as palladium nanoparticles en-
trapped in aluminum oxyhydroxide (Pd/AlO(OH)), displayed
high activity and excellent stability even at 100 °C. These superb
properties encouraged us to further explore its utility as a
component of catalyst for the asymmetric conversion of
ketoximes to chiral amides, in which it acts as a dual catalyst
for both hydrogenation and racemization (Scheme 1). Previously,
we used Pd/C as such a dual catalyst, which required a long
reaction time (5 days) for moderate yields.10
First, we explored the reactions of 1a as a standard substrate
to optimize the reaction conditions. In addition to the Pd
nanocatalyst, thermostable Candida antarctica lipase B (CALB;
trade name, Novozym-435) was chosen as the catalyst for the
enantioselective acylation of amine intermediate with ethyl
methoxyacetate. The acyl donor was chosen because it is more
reactive than other acyl donors such as ethyl acetate and thus
requires much smaller amounts of enzyme.11 The reactions were
carried out with 1 mol% of Pd/AlO(OH), 30 mg/mmol of
Novozym-435, 1.7 equiv of ethyl methoxyacetate in toluene at
70 °C with a variation in hydrogen pressure from 0.05 to 1 bar
for 48 h.
The data from Table 1 indicate that the reaction under 1 atm
of hydrogen afforded unsatisfactory results (71% yield and 87%
ee) with the formation of a significant amount of ethylbenzene
5 as a byproduct (entry 1). This byproduct has been known to
come from a nonproductive pathway including the condensation,
hydrogenation, and deamination of amines.5b Interestingly, the
addition of molecular sieves substantially improved the enan-
tiopurity of product to a satisfactory level with a slight increase
in yield (entry 2). On the other hand, the yield was markedly
enhanced by decreasing the hydrogen pressure. The best results
(90% yield and 98% ee) thus were obtained in the presence of
We have developed an efficient procedure for the asymmetric
synthesis of chiral amides from ketoximes. This one-pot
procedure employs two different types of catalysts, Pd
nanocatalyst and lipase, for three consecutive transformations
including hydrogenation, racemization, and acylation. Eight
ketoximes have been efficiently transformed to the corre-
sponding amides in good yields (83-92%) and high enan-
tiomeric excesses (93-98%).
Optically active amines and their simple derivatives are an
important class of chiral molecules which are useful as chiral
building blocks, auxiliaries, or resolving agents in asymmetric
synthesis.1 A number of methods are currently available for their
asymmetric syntheses.2 For example, asymmetric reductive
amination of ketones provides a useful route to them, particularly
R-chiral amines.3 We herein wish to report an alternative using
Pd nanocatalyst and lipase in combination for the synthesis of
R-chiral amides.4,5 In this one-pot procedure, ketoximes are
converted to optically active amides through three coupled
reactions (hydrogenation, racemization, and enantioselective
acylation) (Scheme 1).
Recently, we have developed a practical Pd nanocatalyst for
use in several reactions including the reduction of olefins,6 the
(1) Breuer, M.; Dietrich, K.; Habicher, T.; Hauer, B.; Kessaeler, M.; Stu¨rmer;
Zelinski, T. Angew. Chem., Int. Ed. 2004, 43, 788–824.
(2) Tararov, V. I.; Bo¨rner, A. Synlett 2005, 203–211.
(3) (a) Nugent, T. C.; Ghosh, A. K.; Wakchaure, V. N.; Mohanty, R. R.
AdV. Synth. Catal. 2006, 348, 1289–1299. (b) Nugent, T. C.; El-Shazly, M.;
Wakchaure, V. N. J. Org. Chem. 2008, 73, 1297–1305.
(6) Kwon, M. S.; Kim, N.; Park, C. M.; Lee, J. S.; Kang, K. Y.; Park, J.
Org. Lett. 2005, 7, 1077–1079.
(7) Kwon, M. S.; Kim, N.; Seo, S. H.; Park, I. S.; Cheedrala, R. K.; Park, J.
Angew. Chem., Int. Ed. 2005, 44, 6913–6915.
(4) Reviews for chemoenzymatic DKR: (a) Kim, M.-J.; Ahn, Y.; Park, J.
Curr. Opin. Biotechnol. 2002, 13, 578–587. (b) Pamies, O.; Ba¨ckvall, J.-E. Chem.
ReV. 2003, 103, 3247–3262. (c) Kim, M.-J.; Park, J.; Ahn, Y. In Biocatalysis in
the Pharmaceutical and Biotechnology Industries; Patel, R. N., Ed.; CRC Press:
Boca Raton, FL, 2007; pp 249-272.
(8) Kwon, M. S.; Park, I. S.; Jang, J. S.; Lee, J. S.; Park, J. Org. Lett. 2007,
9, 3417–3419.
(9) Kim, M.-J.; Kim, W.-H.; Han, K.; Choi, Y. K.; Park, J. Org. Lett. 2007,
9, 1157–1159.
(5) For chemoenzymatic DKRs of amines, see: (a) Reetz, M. T.; Schimossek,
K. Chimia 1996, 50, 668–669. (b) Parvulescu, A.; Vos, D. D.; Jacobs, P. Chem.
Commun. 2005, 5307–5309. (c) Paetzold, J.; Ba¨ckvall, J. E. J. Am. Chem. Soc.
2005, 127, 17620–17621.
(10) Choi, Y. K.; Kim, M. -J.; Ahn, Y. Org. Lett. 2001, 3, 4099–4101.
(11) For molecular modeling study of N-acylation of amine with methoxy-
acetate, see: Cammenberg, M.; Hult, K.; Kim, S. ChemBioChem 2006, 7, 1745–
1749.
4302 J. Org. Chem. 2008, 73, 4302–4304
10.1021/jo800270n CCC: $40.75 2008 American Chemical Society
Published on Web 05/03/2008